BMJ Best Practice

参考文献

关键文献

Public Health England. Immunisation against infectious disease: the Green Book. September 2014 [internet publication].

McLean HQ, Fiebelkorn AP, Temte JL, et al; Centers for Disease Control and Prevention. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2013 Jun 14;62(RR-04):1-34.

Demicheli V, Rivetti A, Debalini MG, et al. Vaccines for measles, mumps and rubella in children. 2012 Feb 15;(2):CD004407.

NHS: when to have vaccinations

参考文章

1.  Cherry JD. Measles virus. In: Cherry JD, Demmler-Harrison GJ, Kaplan SL, et al, eds. Textbook of pediatric infectious diseases. 7th ed. Philadelphia, PA: Saunders; 2014:2373-94.

2.  Public Health England. Immunisation against infectious disease: the Green Book. September 2014 [internet publication].

3.  World Health Organization. Measles. February 2013 [internet publication].

4.  Peltola H, Heinonen OP, Valle M, et al. The elimination of indigenous measles, mumps and rubella from Finland by a 12-year two-dose vaccination program. N Engl J Med. 1994;331:1397-402.

5.  Centers for Disease Control and Prevention. Measles cases and outbreaks. February 2019 [internet publication].

6.  Hyle EP, Rao SR, Jentes ES, et al. Missed opportunities for measles, mumps, rubella vaccination among departing U.S. adult travelers receiving pretravel health consultations. Ann Intern Med. 2017 Jul 18;167(2):77-84.

7.  World Health Organization. Europe observes a 4-fold increase in measles cases in 2017 compared to previous year. February 2018 [internet publication].

8.  World Health Organization. Measles in Europe: record number of both sick and immunized. February 2019 [internet publication].

9.  Strebel PM, Papania MJ, Dayan GH, et al. Measles vaccine. In: Plotkin SA, Orenstein WA, Offit PA, eds. Vaccines. 6th ed. Philadelphia, PA: Elsevier; 2013:352-87.

10.  World Health Organization. Immunization, vaccines and biologicals: measles. November 2017 [internet publication].

11.  Hethcote HW. Measles and rubella in the United States. Am J Epidemiol. 983 Jan;117(1):2-13.

12.  McLean HQ, Fiebelkorn AP, Temte JL, et al; Centers for Disease Control and Prevention. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2013 Jun 14;62(RR-04):1-34.

13.  World Health Organization. Global Measles and Rubella Strategic Plan 2012-2020. 2012 [internet publication].

14.  Robinson CL, Bernstein H, Romerso JR, Szilagyi P. Advisory Committee on Immunization Practices recommended immunization schedule for children and adolescents aged 18 years or younger - United States, 2019. MMWR Morb Mortal Wkly Rep. 2019 Feb 8;68(5):112-4

15.  Public Health England. Complete routine immunisation schedule. July 2017 [internet publication].

16.  Centers for Disease Control and Prevention. CDC Yellow Book 2018: Health Information for International Travel. New York: Oxford University Press; 2017.

17.  American Academy of Pediatrics. Measles. In Kimberlin DW, Brady MT, Jackson MA, Long SS, eds. Red Book: 2015 Report of the Committee on Infectious Diseases. 30th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2015:535-47.

18.  Hambidge SJ, Newcomer SR, Narwaney KJ, et al. Timely versus delayed early childhood vaccination and seizures. Pediatrics. 2014 Jun;133(6):e1492-9.

19.  Klein NP, Lewis E, Fireman B, et al. Safety of measles-containing vaccines in 1-year-old children. Pediatrics. 2015 Feb;135(2):e321-9.

20.  Scott P, Moss WJ, Gilani Z, et al. Measles vaccination in HIV-infected children: systematic review and meta-analysis of safety and immunogenicity. J Infect Dis. 2011 Jul;204 Suppl 1:S164-78.

21.  Kroger AT, Duchin J, Vázquez M. General best practice guidelines for immunization. Best practices guidance of the Advisory Committee on Immunization Practices (ACIP). February 2018 [internet publication].

22.  Public Health England. Revised recommendations for the administration of more than one live vaccine. April 2015 [internet publication].

23.  Demicheli V, Rivetti A, Debalini MG, et al. Vaccines for measles, mumps and rubella in children. 2012 Feb 15;(2):CD004407.

24.  Maglione MA, Das L, Raaen L, et al. Safety of vaccines used for routine immunization of U.S. children: a systematic review. Pediatrics. 2014 Aug;134(2):325-37.

25.  Helfand RF, Heath JL, Anderson LF, et al. Diagnosis of measles with an IgM capture EIA: the optimal timing of specimen collection after rash onset. J Infect Dis. 1997 Jan;175(1):195-9.

26.  Ratnam S, Tipples G, Head C, et al. Performance of indirect immunoglobulin M (IgM) serology tests and IgM capture assays for laboratory diagnosis of measles. J Clin Microbiol. 2000 Jan;38(1):99-104.

27.  Centers of Disease Control and Prevention. Specimens for detection of measles RNA by RT–PCR or virus isolation. July 2017 [internet publication].

28.  Prymula R, Siegrist CA, Chlibek R, et al. Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trials. Lancet. Lancet. 2009 Oct 17;374(9698):1339-50.

29.  Chen RT, Clark TA, Halperin SA. The yin and yang of paracetamol and paediatric immunisations. Lancet. 2009 Oct 17;374(9698):1305-6.

30.  World Health Organization. Weekly epidemiological record: measles and vitamin A. August 2009 [internet publication].

31.  Imdad A, Mayo-Wilson E, Herzer K, et al. Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age. Cochrane Database Syst Rev. 2017 Mar 11;3:CD008524.

32.  Hussey GD, Klein M. A randomized, controlled trial of vitamin A in children with severe measles. N Engl J Med. 1990 Jul 19;323(3):160-4.

33.  Yang HM, Mao M, Wan C. Vitamin A for treating measles in children. Cochrane Database Syst Rev. 2005;(4):CD001479.

34.  Banks G, Fernandez H. Clinical use of ribavirin in measles: a summarized review. In Smith RA, Knight V, Smith JAD, eds. Clinical applications of ribavirin. New York, NY: Academic Press; 1984:203-9.

35.  Ross LA, Kim KS, Mason WH, et al. Successful treatment of disseminated measles in a patient with acquired immunodeficiency syndrome: consideration of antiviral and passive immunotherapy. Am J Med. 1990 Mar;88(3):313-4.

36.  Chen S, Wu T, Kong X, et al. Chinese medicinal herbs for measles. Cochrane Database Syst Rev. 2011;(11):CD005531.

37.  World Health Organization. Subacute sclerosing panencephalitis and measles vaccination. January 2006 [internet publication].

使用此内容应接受我们的免责声明。